Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.6060
-0.0309 (-4.85%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $9.20 million as of April 29, 2025. Its market cap has decreased by -85.25% in one year.
Market Cap
9.20M
Enterprise Value
6.75M
1-Year Change
-85.25%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $9.20M, a decrease of -86.06%. That is a compound annual growth rate of -65.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 9.67M | -63.63% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.19B |
| UnitedHealth Group | 381.84B |
| Johnson & Johnson | 371.38B |
| AbbVie | 335.93B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 224.06B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |